Filing Details

Accession Number:
0001549595-23-000066
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-21 17:19:53
Reporting Period:
2023-12-20
Accepted Time:
2023-12-21 17:19:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1549595 Nurix Therapeutics Inc. NRIX Pharmaceutical Preparations (2834) 270838048
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817217 Hans Houte Van C/O Nurix Therapeutics, Inc.
1700 Owens Street, Suite 205
San Francisco CA 94158
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-20 3,541 $10.00 71,930 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. Represents the weighted average sale price. The lowest price at which shares were sold was $10.00 and the highest price at which shares were sold was $10.03. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.